The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Updated Guidance Issued on Valvular Heart Disease
April 16th 2014The updated valvular heart disease guidelines issued by the American Heart Association and American College of Cardiology now incorporate transcatheter aortic valve implantation, which is now recommended for patients who are not candidates for surgery and would be expected to survive longer than 1 year after intervention.
Transcatheter Aortic-Valve Replacement Deemed Safer than Open-Heart Surgery
April 16th 2014Researchers believe the less-invasive nature of transcatheter aortic-valve replacement systems allows patients to mobilize and recover in as little as one week, which contributes to the device's greater survival benefit compared to open-heart surgery.
New Blood Pressure Guidelines May Take Millions Off Hypertension Medications
New blood pressure treatment guidelines announced in February 2014 by the Eighth Joint National Committee (JNC 8) may result in nearly 6 million American adults no longer requiring hypertension medications.
More on the Controversies Surrounding Implementation of New Lipid Management Guidelines
April 13th 2014The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.
Antihyperglycemic Agent Has No Cardiovascular Effect in Type 2 Diabetics
April 8th 2014Although the US Food and Drug Administration revised its approval processes for antihyperglycemic agents to include cardiovascular safety components, researchers still cannot discern whether those drugs affect cardiovascular outcomes.
New Guidance Issued for Atrial Fibrillation
The American Heart Association, American College of Cardiology, and the Heart Rhythm Society issued updated guidelines that include recommendations on new oral anticoagulants for the management of patients with atrial fibrillation.